ProMIS Neurosciences Inc (PMN) Financials

$12.60

$-0.30 (-2.33%)

As on 04-Sep-2026 16:18EDT

Market cap

$113 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	0.01	0.02
Cost of Revenue	9.36	33.36	--	10.44	0.02	5.85
Gross Profit	-9.36	-33.36	--	-10.44	-0.02	-5.84
Operating Expenses	43.43	40.17	16.83	8.45	23,379.91	4.63
Operating Profit (EBIT)	-43.43	-40.17	-16.83	-18.90	-23,379.91	-10.57
Other Income	--	--	--	--	--	--
Profit before Tax	-42.23	-39.72	2.78	-17.51	-18,062.26	-12.48
Provision for Tax	--	--	--	-0.17	-5.32	0.42
Profit after Tax (Net Income)	-42.23	-39.72	2.78	-17.51	-18,062.26	-11.98
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-18.06	-11.78

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	49.40	-1.26	16.49	3.75	-2.45	7.16
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.08	0.03	0.20	0.52	3.38	14.11
Current Liabilities	7.22	10.41	2.22	9.35	11.67	1.17
Total Liabilities	63.91	9.18	18.91	13.62	12.60	22.44

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	--	--	33.02	--	0.04	0.04
Current Assets	56.69	9.18	18.91	13.62	12.56	22.40
Total Assets	63.91	9.18	18.91	13.62	12.60	22.44
Total Debt*	--	--	--	--	--	4.94
Net Current Assets	49.48	-1.23	16.69	4.27	0.49	16.66

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-28.12	-27.18	-10.84	-22.89	-9.44
Cash Flow from Investing Activities	--	0.00	0.00	0.00	0.00	0.10
Cash from Financing Activities	--	20.94	27.88	17.75	8.73	25.63
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-16.93	-22.61	2.00	-0.93	-53,597.22	-50.59
Cash EPS ($)	--	-22.61	2.00	-0.93	-53,597.19	-50.40
Adjusted Book Value ($)	--	--	11.84	0.20	--	30.23
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-16.00	-19.52	-0.57	-67.92	-39.87
Free Cash Flow per Share ($)	--	-16.00	-19.52	-0.57	-67.92	-39.90

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-521.61	27.46	-2,690.36	-374,551.62	-216.22
ROE (%)	--	-521.61	27.46	-2,690.36	-767,722.75	-390.12
ROA (%)	-101.46	-282.76	17.08	-133.55	-103,098.66	-100.56
EBIT Margin (%)	--	--	--	--	-293,527.91	-56,197.96
Net Margin (%)	--	--	--	--	-221,922,386.04	-71,819.34
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	-1.00	-0.51	9.66
EBIT Growth (%)	-50.43	-101.44	15,248.23	25.33	-154.86	-65.54
Net Profit Growth (%)	-401.09	-1,529.33	115.87	99.90	-150,676.86	-111.56
EPS Growth (%)	-239.44	-12.33	3.15	1.00	-1,058.46	-0.73
Book Value Growth (%)	2,068.79	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.30	0.48	-1.24	0.00	0.00
Price / Book Value	2.37	-9.53	0.08	5.79	-0.60	0.00
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.74	-0.15	-4.20	-0.51	0.00	1.77
Close Price ($)	13.16	6.83	23.70	28.75	108.50	2.85
High Price ($)	39.75	39.75	77.50	223.75	245.00	5.75
Low Price ($)	6.27	6.27	21.75	23.77	1.75	1.53
Market Cap ($ Cr)	112.99	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	--	--	--	0.69
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	7.85	0.88	8.52	1.46	1.08	19.07
Quick Ratio	7.85	--	--	--	1.08	19.11
Interest Coverage	--	--	35,195.02	-88.57	-0.08	-22.52

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	880.03	291.91
Asset Turnover	--	--	--	--	0.00	0.00
Receivable days	--	--	--	--	2,699.68	541.38
Inventory Days	--	--	--	-2.50	-1,458.04	-2.49
Payable days	--	23.43	--	231.78	71,863.45	33.55
Cash Conversion Cycle	--	--	--	--	-70,621.81	505.34

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.